Depression and anxiety in Parkinson's disease

A Schrag, RN Taddei - International review of neurobiology, 2017 - Elsevier
Depression and anxiety are some of the most common comorbidities arising in patients with
Parkinson's disease. However, their timely recognition and diagnosis are often hindered by …

[HTML][HTML] The impact of deep brain stimulation on the quality of life and swallowing in individuals with Parkinson's Disease

MR Olchik, M Ghisi, A Ayres, AFS Schuh… - International …, 2018 - thieme-connect.com
Introduction Deep brain stimulation (DBS) is an established treatment for Parkinson's
disease (PD). However, there is little evidence regarding the effect of DBS on dysphagia …

Patient-reported outcomes measurement information system (PROMIS) assessment of non-motor features in deep brain stimulation candidates: relationship to the …

DW Loring, C Block, E Staikova… - Archives of Clinical …, 2021 - academic.oup.com
Abstract Objective To compare Patient-Reported Outcomes Measurement Information
System (PROMIS) measures of depression and anxiety to the Beck Depression Inventory-II …

[图书][B] Degenerative disorders of the brain

DR Hocking, JL Bradshaw, J Fielding - 2019 - api.taylorfrancis.com
As we age, our bodies undergo widespread and significant changes. Our hair greys and
becomes thinner, our skin wrinkles, our eyesight and hearing become worse. Many people …

New clinical neuroscience technologies for treating neurodegenerative disorders

WP Teo, AM Goodwill, PG Enticott - Degenerative Disorders of the …, 2019 - taylorfrancis.com
This chapter highlights the evidence for the efficacy of repetitive transcranial magnetic
stimulation, Transcranial direct current stimulation (tDCS) and deep brain stimulation (DBS) …

mGluR5 Modulation as a Treatment for Parkinson's Disease

K Farmer - 2018 - repository.library.carleton.ca
Parkinson's disease is an age related neurodegenerative disease. Current treatments do not
reverse the degenerative course; rather they merely manage symptom severity. As such …